Drug Discovery Informatics Market 2027 By Product, Usage, Function, End User | The Insight Partners

Drug Discovery Informatics Market to 2027 - Global Analysis and Forecasts By Product (Services, Software); Usage (In-House Informatics, Outsourced Informatics); Function (Libraries & Database Preparation, Molecular Modelling, Docking, Lead Generation Informatics, Others); End User (Contract Research Organizations (CROs), Pharmaceutical & Biotechnological Companies, Others)

Report Code: TIPHE100000965 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
MARKET INTRODUCTION

Drug Discovery Informatics enables the users to address large volume of data storage & management and processing & analyzing the obtained results. These drug discovery informatics platforms utilize bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data obtained.

MARKET DYNAMICS

Large volume of data procured by innovative methods and the need for an efficient tool to analyze this data are anticipated to drive the market of drug discovery informatics in the coming years. In recent years, various collaborations have been seen amongst the drug discovery informatics providers, which proves to be a major opportunity in the market.

MARKET SCOPE

The "Global Drug Discovery Informatics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global healthcare IT market trend analysis. The report aims to provide an overview of drug discovery informatics market with detailed market segmentation by product, usage, function, end user and geography. The global drug discovery informatics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading drug discovery informatics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global drug discovery informatics market is segmented on the basis of product, usage, function and end user. Based on product, the market is segmented as services and software. On the basis of usage, the global drug discovery informatics market is segmented into in-house informatics and outsourced informatics. On the basis of function, the market is segmented into libraries & database preparations, molecular modelling, docking, lead generation informatics and others. Based on end user, the market is segmented as contract research organizations (CROs), pharmaceutical & biotechnological companies and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global drug discovery informatics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The drug discovery informatics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting drug discovery informatics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the drug discovery informatics market in these regions.

MARKET PLAYERS

The reports cover key developments in the drug discovery informatics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from drug discovery informatics market are anticipated to lucrative growth opportunities in the future with the rising demand for drug discovery informatics in the global market. Below mentioned is the list of few companies engaged in the drug discovery informatics market

The report also includes the profiles of key drug discovery informatics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  PerkinElmer Inc.
  •  Schrodinger, LLC
  •  Certara, L.P.
  •  Infosys Limited
  •  IBM
  •  Collaborative Drug Discovery, Inc.
  •  Jubilant Life Sciences Ltd.
  •  Thermo Fisher Scientific Inc.
  •  Charles River
  •  NOVO INFORMATICS PVT. LTD.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Drug Discovery Informatics Market - By Product
 1.3.2 Drug Discovery Informatics Market - By Usage
 1.3.3 Drug Discovery Informatics Market - By Function
 1.3.4 Drug Discovery Informatics Market - By End User
 1.3.5 Drug Discovery Informatics Market - By Region
 1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG DISCOVERY INFORMATICS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. DRUG DISCOVERY INFORMATICS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DRUG DISCOVERY INFORMATICS MARKET - GLOBAL MARKET ANALYSIS
 6.1. DRUG DISCOVERY INFORMATICS - GLOBAL MARKET OVERVIEW
 6.2. DRUG DISCOVERY INFORMATICS - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG DISCOVERY INFORMATICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
 7.1. OVERVIEW
 7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
 7.3. SERVICES
 7.3.1. Overview
 7.3.2. Services Market Forecast and Analysis
 7.4. SOFTWARE
 7.4.1. Overview
 7.4.2. Software Market Forecast and Analysis
 7.4.3. Discovery Informatics Market
 7.4.3.1. Overview
 7.4.3.2. Discovery Informatics Market Forecast and Analysis
 7.4.4. Development Informatics Market
 7.4.4.1. Overview
 7.4.4.2. Development Informatics Market Forecast and Analysis
8. DRUG DISCOVERY INFORMATICS MARKET - REVENUE AND FORECASTS TO 2027 - USAGE
 8.1. OVERVIEW
 8.2. USAGE MARKET FORECASTS AND ANALYSIS
 8.3. IN-HOUSE INFORMATICS
 8.3.1. Overview
 8.3.2. In-House Informatics Market Forecast and Analysis
 8.4. OUTSOURCED INFORMATICS
 8.4.1. Overview
 8.4.2. Outsourced Informatics Market Forecast and Analysis
9. DRUG DISCOVERY INFORMATICS MARKET - REVENUE AND FORECASTS TO 2027 - FUNCTION
 9.1. OVERVIEW
 9.2. FUNCTION MARKET FORECASTS AND ANALYSIS
 9.3. LIBRARIES & DATABASE PREPARATION
 9.3.1. Overview
 9.3.2. Libraries & Database Preparation Market Forecast and Analysis
 9.4. MOLECULAR MODELLING
 9.4.1. Overview
 9.4.2. Molecular Modelling Market Forecast and Analysis
 9.5. DOCKING
 9.5.1. Overview
 9.5.2. Docking Market Forecast and Analysis
 9.6. LEAD GENERATION INFORMATICS
 9.6.1. Overview
 9.6.2. Lead Generation Informatics Market Forecast and Analysis
 9.7. OTHERS
 9.7.1. Overview
 9.7.2. Others Market Forecast and Analysis
10. DRUG DISCOVERY INFORMATICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
 10.1. OVERVIEW
 10.2. END USER MARKET FORECASTS AND ANALYSIS
 10.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
 10.3.1. Overview
 10.3.2. Contract Research Organizations (CROs) Market Forecast and Analysis
 10.4. PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES
 10.4.1. Overview
 10.4.2. Pharmaceutical & Biotechnological Companies Market Forecast and Analysis
 10.5. OTHERS
 10.5.1. Overview
 10.5.2. Others Market Forecast and Analysis
11. DRUG DISCOVERY INFORMATICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 11.1. NORTH AMERICA
 11.1.1 North America Drug Discovery Informatics Market Overview
 11.1.2 North America Drug Discovery Informatics Market Forecasts and Analysis
 11.1.3 North America Drug Discovery Informatics Market Forecasts and Analysis - By Product
 11.1.4 North America Drug Discovery Informatics Market Forecasts and Analysis - By Usage
 11.1.5 North America Drug Discovery Informatics Market Forecasts and Analysis - By Function
 11.1.6 North America Drug Discovery Informatics Market Forecasts and Analysis - By End User
 11.1.7 North America Drug Discovery Informatics Market Forecasts and Analysis - By Countries
 11.1.7.1 United States Drug Discovery Informatics Market
 11.1.7.1.1 United States Drug Discovery Informatics Market by Product
 11.1.7.1.2 United States Drug Discovery Informatics Market by Usage
 11.1.7.1.3 United States Drug Discovery Informatics Market by Function
 11.1.7.1.4 United States Drug Discovery Informatics Market by End User
 11.1.7.2 Canada Drug Discovery Informatics Market
 11.1.7.2.1 Canada Drug Discovery Informatics Market by Product
 11.1.7.2.2 Canada Drug Discovery Informatics Market by Usage
 11.1.7.2.3 Canada Drug Discovery Informatics Market by Function
 11.1.7.2.4 Canada Drug Discovery Informatics Market by End User
 11.1.7.3 Mexico Drug Discovery Informatics Market
 11.1.7.3.1 Mexico Drug Discovery Informatics Market by Product
 11.1.7.3.2 Mexico Drug Discovery Informatics Market by Usage
 11.1.7.3.3 Mexico Drug Discovery Informatics Market by Function
 11.1.7.3.4 Mexico Drug Discovery Informatics Market by End User
 11.2. EUROPE
 11.2.1 Europe Drug Discovery Informatics Market Overview
 11.2.2 Europe Drug Discovery Informatics Market Forecasts and Analysis
 11.2.3 Europe Drug Discovery Informatics Market Forecasts and Analysis - By Product
 11.2.4 Europe Drug Discovery Informatics Market Forecasts and Analysis - By Usage
 11.2.5 Europe Drug Discovery Informatics Market Forecasts and Analysis - By Function
 11.2.6 Europe Drug Discovery Informatics Market Forecasts and Analysis - By End User
 11.2.7 Europe Drug Discovery Informatics Market Forecasts and Analysis - By Countries
 11.2.7.1 Germany Drug Discovery Informatics Market
 11.2.7.1.1 Germany Drug Discovery Informatics Market by Product
 11.2.7.1.2 Germany Drug Discovery Informatics Market by Usage
 11.2.7.1.3 Germany Drug Discovery Informatics Market by Function
 11.2.7.1.4 Germany Drug Discovery Informatics Market by End User
 11.2.7.2 France Drug Discovery Informatics Market
 11.2.7.2.1 France Drug Discovery Informatics Market by Product
 11.2.7.2.2 France Drug Discovery Informatics Market by Usage
 11.2.7.2.3 France Drug Discovery Informatics Market by Function
 11.2.7.2.4 France Drug Discovery Informatics Market by End User
 11.2.7.3 Italy Drug Discovery Informatics Market
 11.2.7.3.1 Italy Drug Discovery Informatics Market by Product
 11.2.7.3.2 Italy Drug Discovery Informatics Market by Usage
 11.2.7.3.3 Italy Drug Discovery Informatics Market by Function
 11.2.7.3.4 Italy Drug Discovery Informatics Market by End User
 11.2.7.4 Spain Drug Discovery Informatics Market
 11.2.7.4.1 Spain Drug Discovery Informatics Market by Product
 11.2.7.4.2 Spain Drug Discovery Informatics Market by Usage
 11.2.7.4.3 Spain Drug Discovery Informatics Market by Function
 11.2.7.4.4 Spain Drug Discovery Informatics Market by End User
 11.2.7.5 United Kingdom Drug Discovery Informatics Market
 11.2.7.5.1 United Kingdom Drug Discovery Informatics Market by Product
 11.2.7.5.2 United Kingdom Drug Discovery Informatics Market by Usage
 11.2.7.5.3 United Kingdom Drug Discovery Informatics Market by Function
 11.2.7.5.4 United Kingdom Drug Discovery Informatics Market by End User
 11.3. ASIA-PACIFIC
 11.3.1 Asia-Pacific Drug Discovery Informatics Market Overview
 11.3.2 Asia-Pacific Drug Discovery Informatics Market Forecasts and Analysis
 11.3.3 Asia-Pacific Drug Discovery Informatics Market Forecasts and Analysis - By Product
 11.3.4 Asia-Pacific Drug Discovery Informatics Market Forecasts and Analysis - By Usage
 11.3.5 Asia-Pacific Drug Discovery Informatics Market Forecasts and Analysis - By Function
 11.3.6 Asia-Pacific Drug Discovery Informatics Market Forecasts and Analysis - By End User
 11.3.7 Asia-Pacific Drug Discovery Informatics Market Forecasts and Analysis - By Countries
 11.3.7.1 Australia Drug Discovery Informatics Market
 11.3.7.1.1 Australia Drug Discovery Informatics Market by Product
 11.3.7.1.2 Australia Drug Discovery Informatics Market by Usage
 11.3.7.1.3 Australia Drug Discovery Informatics Market by Function
 11.3.7.1.4 Australia Drug Discovery Informatics Market by End User
 11.3.7.2 China Drug Discovery Informatics Market
 11.3.7.2.1 China Drug Discovery Informatics Market by Product
 11.3.7.2.2 China Drug Discovery Informatics Market by Usage
 11.3.7.2.3 China Drug Discovery Informatics Market by Function
 11.3.7.2.4 China Drug Discovery Informatics Market by End User
 11.3.7.3 India Drug Discovery Informatics Market
 11.3.7.3.1 India Drug Discovery Informatics Market by Product
 11.3.7.3.2 India Drug Discovery Informatics Market by Usage
 11.3.7.3.3 India Drug Discovery Informatics Market by Function
 11.3.7.3.4 India Drug Discovery Informatics Market by End User
 11.3.7.4 Japan Drug Discovery Informatics Market
 11.3.7.4.1 Japan Drug Discovery Informatics Market by Product
 11.3.7.4.2 Japan Drug Discovery Informatics Market by Usage
 11.3.7.4.3 Japan Drug Discovery Informatics Market by Function
 11.3.7.4.4 Japan Drug Discovery Informatics Market by End User
 11.3.7.5 South Korea Drug Discovery Informatics Market
 11.3.7.5.1 South Korea Drug Discovery Informatics Market by Product
 11.3.7.5.2 South Korea Drug Discovery Informatics Market by Usage
 11.3.7.5.3 South Korea Drug Discovery Informatics Market by Function
 11.3.7.5.4 South Korea Drug Discovery Informatics Market by End User
 11.4. MIDDLE EAST AND AFRICA
 11.4.1 Middle East and Africa Drug Discovery Informatics Market Overview
 11.4.2 Middle East and Africa Drug Discovery Informatics Market Forecasts and Analysis
 11.4.3 Middle East and Africa Drug Discovery Informatics Market Forecasts and Analysis - By Product
 11.4.4 Middle East and Africa Drug Discovery Informatics Market Forecasts and Analysis - By Usage
 11.4.5 Middle East and Africa Drug Discovery Informatics Market Forecasts and Analysis - By Function
 11.4.6 Middle East and Africa Drug Discovery Informatics Market Forecasts and Analysis - By End User
 11.4.7 Middle East and Africa Drug Discovery Informatics Market Forecasts and Analysis - By Countries
 11.4.7.1 South Africa Drug Discovery Informatics Market
 11.4.7.1.1 South Africa Drug Discovery Informatics Market by Product
 11.4.7.1.2 South Africa Drug Discovery Informatics Market by Usage
 11.4.7.1.3 South Africa Drug Discovery Informatics Market by Function
 11.4.7.1.4 South Africa Drug Discovery Informatics Market by End User
 11.4.7.2 Saudi Arabia Drug Discovery Informatics Market
 11.4.7.2.1 Saudi Arabia Drug Discovery Informatics Market by Product
 11.4.7.2.2 Saudi Arabia Drug Discovery Informatics Market by Usage
 11.4.7.2.3 Saudi Arabia Drug Discovery Informatics Market by Function
 11.4.7.2.4 Saudi Arabia Drug Discovery Informatics Market by End User
 11.4.7.3 U.A.E Drug Discovery Informatics Market
 11.4.7.3.1 U.A.E Drug Discovery Informatics Market by Product
 11.4.7.3.2 U.A.E Drug Discovery Informatics Market by Usage
 11.4.7.3.3 U.A.E Drug Discovery Informatics Market by Function
 11.4.7.3.4 U.A.E Drug Discovery Informatics Market by End User
 11.5. SOUTH AND CENTRAL AMERICA
 11.5.1 South and Central America Drug Discovery Informatics Market Overview
 11.5.2 South and Central America Drug Discovery Informatics Market Forecasts and Analysis
 11.5.3 South and Central America Drug Discovery Informatics Market Forecasts and Analysis - By Product
 11.5.4 South and Central America Drug Discovery Informatics Market Forecasts and Analysis - By Usage
 11.5.5 South and Central America Drug Discovery Informatics Market Forecasts and Analysis - By Function
 11.5.6 South and Central America Drug Discovery Informatics Market Forecasts and Analysis - By End User
 11.5.7 South and Central America Drug Discovery Informatics Market Forecasts and Analysis - By Countries
 11.5.7.1 Brazil Drug Discovery Informatics Market
 11.5.7.1.1 Brazil Drug Discovery Informatics Market by Product
 11.5.7.1.2 Brazil Drug Discovery Informatics Market by Usage
 11.5.7.1.3 Brazil Drug Discovery Informatics Market by Function
 11.5.7.1.4 Brazil Drug Discovery Informatics Market by End User
 11.5.7.2 Argentina Drug Discovery Informatics Market
 11.5.7.2.1 Argentina Drug Discovery Informatics Market by Product
 11.5.7.2.2 Argentina Drug Discovery Informatics Market by Usage
 11.5.7.2.3 Argentina Drug Discovery Informatics Market by Function
 11.5.7.2.4 Argentina Drug Discovery Informatics Market by End User
12. INDUSTRY LANDSCAPE
 12.1. MERGERS AND ACQUISITIONS
 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 12.3. NEW PRODUCT LAUNCHES
 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DRUG DISCOVERY INFORMATICS MARKET, KEY COMPANY PROFILES
 13.1. PERKINELMER INC.
 13.1.1. Key Facts
 13.1.2. Business Description
 13.1.3. Products and Services
 13.1.4. Financial Overview
 13.1.5. SWOT Analysis
 13.1.6. Key Developments
 13.2. SCHRöDINGER, LLC
 13.2.1. Key Facts
 13.2.2. Business Description
 13.2.3. Products and Services
 13.2.4. Financial Overview
 13.2.5. SWOT Analysis
 13.2.6. Key Developments
 13.3. CERTARA, L.P.
 13.3.1. Key Facts
 13.3.2. Business Description
 13.3.3. Products and Services
 13.3.4. Financial Overview
 13.3.5. SWOT Analysis
 13.3.6. Key Developments
 13.4. INFOSYS LIMITED
 13.4.1. Key Facts
 13.4.2. Business Description
 13.4.3. Products and Services
 13.4.4. Financial Overview
 13.4.5. SWOT Analysis
 13.4.6. Key Developments
 13.5. IBM
 13.5.1. Key Facts
 13.5.2. Business Description
 13.5.3. Products and Services
 13.5.4. Financial Overview
 13.5.5. SWOT Analysis
 13.5.6. Key Developments
 13.6. COLLABORATIVE DRUG DISCOVERY, INC.
 13.6.1. Key Facts
 13.6.2. Business Description
 13.6.3. Products and Services
 13.6.4. Financial Overview
 13.6.5. SWOT Analysis
 13.6.6. Key Developments
 13.7. JUBILANT LIFE SCIENCES LTD.
 13.7.1. Key Facts
 13.7.2. Business Description
 13.7.3. Products and Services
 13.7.4. Financial Overview
 13.7.5. SWOT Analysis
 13.7.6. Key Developments
 13.8. THERMO FISHER SCIENTIFIC INC.
 13.8.1. Key Facts
 13.8.2. Business Description
 13.8.3. Products and Services
 13.8.4. Financial Overview
 13.8.5. SWOT Analysis
 13.8.6. Key Developments
 13.9. CHARLES RIVER
 13.9.1. Key Facts
 13.9.2. Business Description
 13.9.3. Products and Services
 13.9.4. Financial Overview
 13.9.5. SWOT Analysis
 13.9.6. Key Developments
 13.10. NOVO INFORMATICS PVT. LTD.
 13.10.1. Key Facts
 13.10.2. Business Description
 13.10.3. Products and Services
 13.10.4. Financial Overview
 13.10.5. SWOT Analysis
 13.10.6. Key Developments
14. APPENDIX
 14.1. ABOUT THE INSIGHT PARTNERS
 14.2. GLOSSARY OF TERMS

 

The List of Companies

1. PerkinElmer Inc.
2. Schrodinger, LLC
3. Certara, L.P.
4. Infosys Limited
5. IBM
6. Collaborative Drug Discovery, Inc.
7. Jubilant Life Sciences Ltd.
8. Thermo Fisher Scientific Inc.
9. Charles River
10. NOVO INFORMATICS PVT. LTD.